Clough Capital Partners’s Celgene Corp CELG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q2
Sell
-96,147
Closed -$8.58M 167
2018
Q1
$8.58M Sell
96,147
-6,900
-7% -$662K 0.82% 47
2017
Q4
$10.8M Buy
103,047
+32,200
+45% +$3.63M 0.9% 35
2017
Q3
$10.3M Sell
70,847
-37,900
-35% -$5.16M 0.69% 46
2017
Q2
$14.1M Buy
108,747
+10,747
+11% +$1.32M 0.98% 31
2017
Q1
$12.2M Sell
98,000
-37,676
-28% -$4.51M 0.77% 40
2016
Q4
$15.7M Buy
135,676
+77,476
+133% +$8.63M 1.04% 35
2016
Q3
$6.08M Buy
+58,200
New +$6.3M 0.32% 87
2014
Q2
Sell
-79,026
Closed -$5.52M 239
2014
Q1
$5.52M Sell
79,026
-219,224
-74% -$17.4M 0.17% 128
2013
Q4
$25.2M Buy
298,250
+144,800
+94% +$11.5M 0.83% 41
2013
Q3
$11.8M Sell
153,450
-128,350
-46% -$8.99M 0.37% 109
2013
Q2
$16.5M Buy
+281,800
New +$17M 0.55% 67

Other funds holding CELG

Clough Capital Partners's CELG Position: Q2 2018 in Review

Clough Capital Partners sold out of Celgene Corp (CELG) in Q2 2018, closing a stake of 96,147 shares — an estimated $8.58M sold.

Clough Capital Partners first reported a position in CELG in Q2 2013 and held it in 11 quarters. The position peaked at $25.2M in Q4 2013. 1,360 funds tracked by Wall St. Rank hold CELG as of Q2 2018.

  • Clough Capital Partners reported no remaining Celgene Corp position as of Q2 2018 after selling out during the quarter.
  • Clough Capital Partners sold 96,147 Celgene Corp shares in Q2 2018, an estimated $8.58M.
  • Clough Capital Partners first reported a position in Celgene Corp in Q2 2013 and held it in 11 quarters.
  • Clough Capital Partners's Celgene Corp position peaked at $25.2M in Q4 2013.
  • 1,360 funds tracked by Wall St. Rank held Celgene Corp as of Q2 2018.

Based on Clough Capital Partners's 13F filing for Q2 2018, filed 14 Aug 2018.